$0.87 -$0.01 (-0.7%)

04:30 PM EDT on 07/09/20

Second Sight Med Prods Inc (NASDAQ:EYES)

CAPS Rating: 1 out of 5

Current Price $0.87 Mkt Cap $20.2M
Open $0.87 P/E Ratio 0.00
Prev. Close $0.87 Div. (Yield) $0.00 (0.0%)
Daily Range $0.82 - $0.87 Volume 346,231
52-Wk Range $0.71 - $8.96 Avg. Daily Vol. 1,185,071

Caps

How do you think NASDAQ:EYES will perform against the market?

Add Stock to CAPS Watchlist

All Players

17 Outperform
13 Underperform
 

All-Star Players

1 Outperform
10 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EYES Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

dlcarden (30.32)
Submitted November 29, 2014

This one's a gamble in every sense of the word, but EYES develops disruptive technologies with little-to-no competition. I keep hearing $35 being batted around as the target price but if they succeed the stock will soar like Google and Amazon. 3 to 5… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:EYES VS S&P 500 (SPY)

NASDAQ:EYES Summary

Fools bullish on NASDAQ:EYES are also bullish on:

Fools bearish on NASDAQ:EYES are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EYES.

Recs

0
Member Avatar msj1819 (< 20) Submitted: 7/29/2015 2:42:17 PM : Outperform Start Price: $13.92 NASDAQ:EYES Score: -142.95

Once their Argus product line hits larger distribution for both retinitis pigmentosa and, newly announced as effective for macular degeneration, the market penetration becomes much broader, production costs at volume will go down, and people will recognize the value of the stock as well as its products.

Recs

0
Member Avatar TurbulentTime (57.38) Submitted: 7/17/2015 6:07:10 AM : Outperform Start Price: $14.75 NASDAQ:EYES Score: -142.19

It has real results, patients regain eyesight. Newer version is under testing phrase and is expected to do a much better job and gain wider acceptance and traction for implants.

Recs

0
Member Avatar manirg (< 20) Submitted: 3/27/2015 2:53:31 PM : Outperform Start Price: $12.75 NASDAQ:EYES Score: -144.89

Has a proven and working technology. Undervalued at ~$13, potential $24 in a year or so.............

Leaderboard

Find the members with the highest scoring picks in EYES.

Score Leader

glenn12345

glenn12345 (99.86) Score: +365.37

The Score Leader is the player with the highest score across all their picks in EYES.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
FunesDMemorious 31.43 2/24/2016 Underperform 5Y $6.49 -86.74% +64.79% +151.53 0 Comment
RyanIdaho 94.07 3/12/2020 Underperform 5Y $3.89 -77.89% +22.75% +100.64 0 Comment
cashole 99.74 4/23/2020 Underperform 5Y $1.93 -55.44% +11.95% +67.38 0 Comment
constructive 99.10 8/7/2017 Underperform 5Y $1.15 -25.21% +26.83% +52.04 0 Comment
Fox660Player 99.86 5/13/2020 Underperform 5Y $0.96 -10.03% +11.62% +21.65 0 Comment
WSMOOT19 73.42 5/28/2020 Underperform 1Y $0.96 -10.41% +3.23% +13.63 0 Comment
FoolTheRest 99.97 6/2/2020 Underperform 5Y $0.96 -10.41% +2.57% +12.97 0 Comment
whatsthepoint 99.99 7/6/2020 Underperform 5Y $0.98 -12.23% -0.69% +11.54 0 Comment
anchak 99.92 4/7/2020 Underperform 5Y $0.82 +5.22% +15.79% +10.57 0 Comment
Strawfidl < 20 2/4/2019 Underperform 5Y $0.79 +9.43% +16.34% +6.92 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EYES.